Cemsel Bafligil

Dr. Cemsel Bafligil

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2020 in BMC Medicine
Verified
Journal Article
Open access
PDF file
MGManman Guo
Manman Guo
CBCemsel Bafligil
Cemsel Bafligil
TTThomas Tapmeier
Thomas Tapmeier
CHCarol Hubbard
Carol Hubbard
SMSanjiv Manek
Sanjiv Manek
UOUdo Oppermann
Udo Oppermann
Background: Endometriosis is a gynaecological condition characterised by immune cell infiltration and distinct inflammatory signatures found in the peritoneal cavity. In this study, we aim to characterise the immune microenvironment in samples isolated from the peritoneal cavity in patients with endometriosis.Methods: We applied mass cytometry (CyTOF), a recently developed multiparameter single-cell technique, in order to characterise and quantify the immune cells found in peritoneal fluid and peripheral blood from endometriosis and control patients.Results: Our results demonstrate the presence of more than 40 different distinct immune cell types within the peritoneal cavity. This suggests that there is a complex and highly heterogeneous inflammatory microenvironment underpinning the pathology of endometriosis. Stratification by clinical disease stages reveals a dynamic spectrum of cell signatures suggesting that adaptations in the inflammatory system occur due to the severity of the disease. Notably, among the inflammatory microenvironment in peritoneal fluid (PF), the presence of CD69+T cell subsets is increased in endometriosis when compared to control patient samples. On these CD69+cells, the expression of markers associated with T cell function are reduced in PF samples compared to blood. Comparisons between CD69+and CD69−populations reveal distinct phenotypes across peritoneal T cell lineages. Taken together, our results suggest that both the innate and the adaptive immune system play roles in endometriosis.Conclusions: This study provides a systematic characterisation of the specific immune environment in the peritoneal cavity and identifies cell immune signatures associated with endometriosis. Overall, our results provide novel insights into the specific cell phenotypes governing inflammation in patients with endometriosis. This prospective study offers a useful resource for understanding disease pathology and opportunities for identifying therapeutic targets.

25 August 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
TTThomas T. Tapmeier
Thomas T. Tapmeier
NRNilufer Rahmioglu
Nilufer Rahmioglu
JLJianghai Lin
Jianghai Lin
BLBianca De Leo
Bianca De Leo
MOMaik Obendorf
Maik Obendorf
KZKrina Zondervan
Krina Zondervan
Genetic analyses in humans and macaques followed by cellular and mouse studies demonstrate NPSR1 as a nonhormonal drug target in endometriosis.

17 February 2020 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
CBCemsel Bafligil
Cemsel Bafligil
DTDeborah J Thompson
Deborah J Thompson
ALArtitaya Lophatananon
Artitaya Lophatananon
MSMiriam J. Smith
Miriam J. Smith
NRNeil Ryan
Neil Ryan
ECEmma Crosbie
Emma Crosbie
Introduction: Endometrial cancer is one of the most commonly diagnosed cancers in women. Although there is a hereditary component to endometrial cancer, most cases are thought to be sporadic and lifestyle related. The aim of this study was to systematically review prospective and retrospective case–control studies, meta-analyses and genome-wide association studies to identify genomic variants that may be associated with endometrial cancer risk. Methods: We searched MEDLINE, Embase and CINAHL from 2007 to 2019 without restrictions. We followed PRISMA 2009 guidelines. The search yielded 3015 hits in total. Following duplicate exclusion, 2674 abstracts were screened and 453 full-texts evaluated based on our pre-defined screening criteria. 149 articles were eligible for inclusion. Results: We found that single nucleotide polymorphisms (SNPs) in HNF1B, KLF, EIF2AK, CYP19A1, SOX4 and MYC were strongly associated with incident endometrial cancer. Nineteen variants were reported with genome-wide significance and a further five with suggestive significance. No convincing evidence was found for the widely studied MDM2 variant rs2279744. Publication bias and false discovery rates were noted throughout the literature. Conclusion: Endometrial cancer risk may be influenced by SNPs in genes involved in cell survival, oestrogen metabolism and transcriptional control. Larger cohorts are needed to identify more variants with genome-wide significance.

1 September 2020 in European Journal of Cancer
Verified
Journal Article
Open access
SKSarah Kitson
Sarah Kitson
CBCemsel Bafligil
Cemsel Bafligil
NRNeil Ryan
Neil Ryan
FLFiona Lalloo
Fiona Lalloo
EWEmma R. Woodward
Emma R. Woodward
D. Gareth EvansD. Gareth Evans
D. Gareth Evans
An association between BRCA pathogenic variants and an increased endometrial cancer risk, specifically serous-like endometrial cancer, has been postulated but remains unproven, particularly for BRCA2 carriers. Mechanistic evidence is lacking, and any link may be related to tamoxifen exposure or testing bias. Hysterectomy during risk-reducing bilateral salpingo-oophorectomy is, therefore, of uncertain benefit. Data from a large, prospective cohort will be informative. Data on UK BRCA pathogenic variant carriers were interrogated for endometrial cancer diagnoses. Standardised incidence ratios (SIRs) were calculated in four distinct cohorts using national endometrial cancer rates; either from 1/1/1980 or age 20, prospectively from date of personal pathogenic variant report, date of family pathogenic variant report or date of risk-reducing salpingo-oophorectomy. Somatic BRCA sequencing of 15 serous endometrial cancers was performed to detect pathogenic variants. Fourteen cases of endometrial cancer were identified in 2609 women (1350 BRCA1 and 1259 BRCA2), of which two were prospectively diagnosed. No significant increase in either overall or serous-like endometrial cancer risk was identified in any of the cohorts examined (SIR = 1.70, 95% confidence interval = 0.74–3.33; no cases of serous endometrial cancer diagnosed). Results were unaffected by the BRCA gene affected, previous breast cancer or tamoxifen use. No BRCA pathogenic variants were detected in any of the serous endometrial cancers tested. Women with a BRCA pathogenic variant do not appear to have a significant increased risk of all-type or serous-like endometrial cancer compared with the general population. These data provide some reassurance that hysterectomy is unlikely to be of significant benefit if performed solely as a preventive measure.

18 October 2023 in Annals of Neurology
Verified
Journal Article
Open access
PDF file
CGChristiane Gasperi
Christiane Gasperi
TWTun Wiltgen
Tun Wiltgen
JMJulian McGinnis
Julian McGinnis
SCStefano Cerri
Stefano Cerri
TMThomas Moridi
Thomas Moridi
MMMark Mühlau
Mark Mühlau
The minor allele of the genetic variant rs10191329 in the DYSF‐ZNF638 locus is associated with unfavorable long‐term clinical outcomes in multiple sclerosis patients. We investigated if rs10191329 is associated with brain atrophy measured by magnetic resonance imaging in a discovery cohort of 748 and a replication cohort of 360 people with relapsing multiple sclerosis. We observed an association with 28% more brain atrophy per rs10191329*A allele. Our results encourage stratification for rs10191329 in clinical trials. Unraveling the underlying mechanisms may enhance our understanding of pathophysiology and identify treatment targets. ANN NEUROL 2023;94:1080–1085

30 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MTMarie-Laëtitia Thézénas
Marie-Laëtitia Thézénas
BLBianca De Leo
Bianca De Leo
ALAlexis Laux-Biehlmann
Alexis Laux-Biehlmann
CBCemsel Bafligil
Cemsel Bafligil
BEBernd Elger
Bernd Elger
UOUdo Oppermann
Udo Oppermann
Endometriosis is a common gynaecological disease of women in reproductive age, and is thought to arise from retrograde menstruation and implantation of endometrial tissue, mostly into the peritoneal cavity. The condition is characterized by a chronic, unresolved inflammatory process thereby contributing to pain as cardinal symptom in endometriosis. Elevated reactive oxygen species (ROS) and oxidative stress have been postulated as factors in endometriosis pathogenesis. We here set out for a systematic study to identify novel mechanisms and pathways relating to oxidative stress in ectopic peritoneal lesions. Using combined proteomic and transcriptomic approaches, we identified novel targets including upregulated pro-oxidative enzymes, such as amine oxidase 3/vascular adhesion protein 1 (AOC3/VAP1) as well as downregulated protective factors, in particular alkenal reductase PTGR1 and methionine sulfoxide reductase. Consistent with an altered ROS landscape, we observed hemoglobin / iron overload, ROS production and lipid peroxidation in ectopic lesions. ROS-derived 4-hydroxy-2-nonenal induced interleukin IL-8 release from monocytes. Notably, AOC3 inhibitors provoked analgesic effects in inflammatory pain models in vivo, suggesting potential translational applicability.